Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Superinvestors holding CMMB, Q2 2026
No superinvestor reported holding CMMB in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CMMB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2022
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−99.7%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+48.1%)
Q3 2021
1 superinvestor holding at quarter end
- New
- ARK Invest